Vygenerované: 25.09.2026 18:59:37
Súhrn: TOPLINE Among eyes with polypoidal choroidal vasculopathy (PCV) — a subtype of age-related macular degeneration — that achieved complete regression after receiving either three or six monthly injections of aflibercept, half stayed fluid-free for up to 2 years with an as-needed treatment approach, while the other half experienced recurrence METHODOLOGY - Researchers conducted a prospective cohort study to evaluate how long eyes with PCV could stay free of recurrence after achieving regression with aflibercept and whether an as-needed treatment approach preserved vision outcomes - They enrolled 81 participants with PCV who had not previously received treatment (mean age, 64 years; 54% women) and received three monthly injections of 2 mg aflibercept.
Doplnenie: - They enrolled 81 participants with PCV who had not previously received treatment (mean age, 64 years; 54% women) and received three monthly injections of 2 mg aflibercept.
Súhrn: METHODOLOGY - Researchers conducted an observational study to examine the long-term outcomes of implanting a permanent pacemaker or ICD shortly after cardiac surgery - Researchers identified patients who had permanent pacemakers or ICDs implanted within 30 days after surgery TOPLINE Patients implanted with a permanent pacemaker after cardiac surgery had increased risks for death and hospitalization for heart failure.
Doplnenie: - They used Swedish registries and included 76,223 adults who underwent cardiac surgery between 2006 and 2020.
Súhrn: The leading cause of death on the job for these “tactical athletes” is actually cardiovascular disease The writing group designed a new evidence-based tactical clinical management framework to guide clinicians in risk assessment, medical evaluation, diagnosis, and treatment - Preparticipation screening for all tactical athletes, including a physical examination and medical history.
Doplnenie: Clinical guidance for these distinctive athletes has lagged well behind that for competitive athletes, but a new scientific statement from the American College of Cardiology and the American Heart Association hopes to close that gap.
Súhrn: For patients undergoing surgery to remove a brain tumour where the exact tumour type is not known, the test can be done and the results delivered to the surgeon while the operation is still under way — helping them decide how much of the tumour to safely remove while protecting healthy brain tissue Receiving a precise diagnosis sooner means patients can start treatment — including radiotherapy and chemotherapy — earlier if needed, and could spare them weeks of anxiety The faster diagnosis will also help patients access suitable clinical trials earlier, said Professor Frankie Swords, NHS medical director, in a press release.
Doplnenie: For patients undergoing surgery to remove a brain tumour where the exact tumour type is not known, the test can be done and the results delivered to the surgeon while the operation is still under way — helping them decide how much of the tumour to safely remove while protecting healthy brain tissue.